Viewing data from:

MIGERGOT

ANDA

CAFFEINE; ERGOTAMINE TARTRATE | A086557 | COSETTE PHARMACEUTICALS INC

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Migergot (2023)

Total Spending

$2.4M

Total Claims

594

Beneficiaries

Avg Cost/Unit

$182.95

Spending Trend

$238K(2019)→$2.7M(2020)→$2.8M(2021)→$2.7M(2022)→$2.4M(2023)

YoY Change:+10.9%

5yr CAGR:+10.4%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 100MG;2MG

RLD

0 patents0 exclusivities▴

SUPPOSITORY;RECTAL | Approved: Oct 4, 1983

No patent or exclusivity listings for this strength.